Generics 3

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Acrivastine manufacturers

3 products found

Filters

3 products found

acrivastine + pseudoephedrine hydrochloride

Capsules 8 mg + 60 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Denmark , Finland , Norway , Saudi Arabia , Sweden
Comments
The supplier does not offer tech transfer deal type
Manufacturer #1765
A pharmaceutical manufacturer based in the EU that is active in 10+ countries selling its products in Europe, CIS, Asia, and the East for 20+ years. The production facilities are cGMP compliant. The main dosage forms are solid dosage forms. The company provides documentation in CTD/eCTD format and stability studies. The company has several branches in Europe.

Manufacturer usually replies in 6 days

Want to see all 3 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Acrivastine:

Acrivastine is a medication which is used for the treatment of various allergies and hay fever. It belongs to a group of drugs termed second-generation H1-receptor antagonist antihistamine and is based on the molecule triprolidine. It is for sale under the popular brand name Benadryl Allergy Relief in the United Kingdom and should not be confused with Benadryl Once a Day which utilises cetirizine as the active ingredient and is also sold by McNeil in the UK, nor with the American Benadryl, which uses diphenhydramine as its active ingredient.

It was originally developed by a pharmaceutical products manufacturing company and has since found wide popularity on the global medical marketplace. Being available for order in many countries including the United States, where it has gained regulatory approval in combination with pseudoephedrine as the FDA-approved product Semprex-D. This and its generic nature have spurred its adoption by acrivastine manufactures and acrivastine suppliers. Where it can currently be commonly found on the pharmaceutical products list of global distributors for wholesale at a variety of cost and price points.

Method of action of acrivastine:

Being a member of the second-generation H1-receptor antagonist antihistamines, it functions through much of the same pathways. Working through the blockading of histamine H1 receptors. Preventing the downstream effects of histamine from taking place, subsequently alleviating the symptoms of allergies and other similar indications.

Form and dosage of acrivastine:

The final form and packaging are dependent on the manufacturers and suppliers, as well as the distributors and order. However, acrivastine is typically found wholesale in forms including tablets and capsules. Acrivastine is available as an over the counter medication and the recommended dose for both adults and children over the age of 12 to alleviate symptoms of allergies, is 8 mg 3 times a day as needed by mouth. For more information and possible side effects please contact a healthcare professional or refer to the manufacturers’ literature.

Acrivastine on Pipelinepharma:

Currently, at the time of writing, we have found 1 verified seller from our online global list of B2B acrivastine manufacturers and acrivastine suppliers. These manufactures, suppliers, and distributors and their pharmaceutical products list have each been verified by the Pipelinepharma team in a time-intensive manner. As such, it is likely that more acrivastine manufacturers and acrivastine suppliers are awaiting approval and will be displayed on our online B2B company marketplace shortly.

Price of acrivastine and how to buy:

A cursory search online reveals an approximate wholesale cost for acrivastine to be £3.20 for 12 x 8 mg capsules. These values are indicated exclusively for the NHS in the UK using the drug tariff Part VIIIA Category C. As such they are only intended to serve as a generalization of the current market conditions in a specific area and a specific form.

Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence. This makes it easy to find new qualified sellers for your pharmaceutical business. Simply use our online search tool, filter by your wanted criteria, and finally select the desired listing.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation